Deville SS, Vehlow A, Förster S, Dickreuter E, Borgmann K, Cordes N.
The Intermediate Filament Synemin Regulates Non-Homologous End Joining in an ATM-Dependent Manner.
Cancers (Basel). 2020;12(7):E1717.


Vehlow A, Cordes N. DDR1 (discoidin domain receptor tyrosine kinase 1) drives glioblastoma therapy resistance by modulating autophagy. Autophagy. 2019 doi: 10.1080/15548627.2019.1618540

Vehlow A, Klapproth E, Jin S, Hannen R, Hauswald M, Bartsch JW, Nimsky C,
Temme A, Leitinger B, Cordes N. Interaction of Discoidin Domain Receptor 1 with a
14-3-3-Beclin-1-Akt1 Complex Modulates Glioblastoma Therapy Sensitivity.
Rep. 2019 Mar 26;26(13):3672-3683.e7.


Naumann M, Pal A, Goswami A, Lojewski X, Japtok J, Vehlow A, Naujock M, Günther R, Jin M, Stanslowsky N, Reinhardt P, Sterneckert J, Frickenhaus M, Pan-Montojo F, Storkebaum E, Poser I, Freischmidt A, Weishaupt JH, Holzmann K, Troost D, Ludolph AC, Boeckers TM, Liebau S, Petri S, Cordes N, Hyman AA, Wegner F, Grill SW, Weis J, Storch A, Hermann A (2018). Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation. Nature Communications 9(1):335

Vehlow A, Klapproth E, Storch K, Dickreuter E, Seifert M, Dietrich A, Bütof R, Temme A, Cordes N (2017). Adhesion- and stress-related adaptation of glioma radiochemoresistance is circumvented by β1 integrin/JNK co-targeting. Oncotarget. 2017 Apr 27. doi: 10.18632/oncotarget.17480.

Vehlow A, Storch K, Matzke D, Cordes N (2016). Molecular Targeting of Integrins and Integrin-Associated Signaling Networks in Radiation Oncology.  Recent Results Cancer Res. 2016;198:89-106

Dickreuter E, Vehlow A, Cordes N (2015). 3D-Zellkultur zur Identifizierung von Zielmolekülen für die Krebstherapie. BIOspektrum 21(4):397-400.

Steglich A, Vehlow A, Eke I, Cordes N (2015). α integrin targeting for radiosensitization of three-dimensionally grown human head and neck squamous cell carcinoma cells. Cancer Letters 357(2):542-8.

Law AL, Vehlow A, Kotini M, Dodgson L, Soong D, Theveneau E, Bodo C, Taylor E, Navarro C, Perera U, Michael M, Dunn GA, Bennett D, Mayor R, Krause M (2013). Lamellipodin and the Scar/WAVE complex cooperate to promote cell migration in vivo. Journal of Cell Biology 203(4):673-89

Vehlow A, Soong D, Vizcay-Barrena G, Bodo C, Law AL, Perera U, Krause M (2013).  Endophilin, Lamellipodin, and Mena cooperate to regulate F-actin-dependent EGF-receptor endocytosis. EMBO Journal 32(20):2722-34

Vehlow A, Cordes N (2013). Invasion as target for therapy of glioblastoma multiforme. Biochimica et Biophysica Acta 1836(2):236-44

Eke I & Storch K, Kästner I, Vehlow A, Faethe C, Mueller-Klieser W, Taucher-Scholz G, Temme A, Schackert G, Cordes N (2012). Three-dimensional invasion of human glioblastoma cells remains unchanged by X-ray and carbon ion irradiation in vitro. International Journal of Radiation Oncology, Biology, Physics 84(4):515-23

Michael M, Vehlow A, Navarro C, Krause M (2010). C-Abl, Lamellipodin, and Ena/VASP proteins cooperate in dorsal ruffling of fibroblasts and axonal morphogenesis. Current Biology 20(9):783-91

Henderson RB, Grys K, Vehlow A, de Bettignies C, Zachacz A, Henley T, Turner M, Batista F, Tybulewicz VL (2010). A novel Rac-dependent checkpoint in B cell development controls entry into the splenic white pulp and cell survival. Journal of Experimental Medicine 207(4):837-53

Lyulcheva E, Taylor E, Michael M, Vehlow A, Tan S, Fletcher A, Krause M and Bennett D (2008). Drosophila Pico and Its Mammalian Ortholog Lamellipodin Activate Serum Response Factor and Promote Cell Proliferation. Developmental Cell 15(5):680-690

Arana E* & Vehlow A*, Harwood NE, Vigorito E, Henderson R, Turner M, Tybulewicz VLJ and Batista FD (2008). Activation of the Small GTPase Rac2 via the B Cell Receptor Regulates B Cell Adhesion and Immunological-Synapse Formation. Immunity 28(1):88-99  *Co-first authors

Batista FD, Arana E, Barral P, Carrasco YR, Depoil D, Eckl-Dorna J, Fleire S, Howe K, Vehlow A, Weber M and Treanor B (2007). The role of integrins and coreceptors in refining thresholds for B-cell responses. Immunological Reviews 218:197-213